Ariad Pharmaceuticals Inc fka ARIA

[rurik]

lax - I wish I could give you a schedule. The clinical data sure points the way that this has to go in the long run. It would be interesting to here the discussions about it which I am certain exist. This might easily be a partnering possibility.

The other interesting thing is the problem they have is selection a candidate for nM. This is a forced choice for financial reasons which obscures the fact that there is more than one significant molecule to consider. This in turn brings up the old question of how many molecules do they have and at what stage of development are they and how valuable might they turn out to be.



I remain convinced that the true value of Ariad can only be brought out with a buy out on friendly terms where dew diligence makes the lab accessible to the acquiring party. Just hope its sooner rather than later.

Best wishes to all of you for the holidays and may the New Year bring a bountiful Ariad.